X

pharmaceuticals

Earnings|Abbott India Ltd (NSE:ABBOTTINDIA) : Q3FY23 Results Out; Total Income rise 10% YoY

Abbott India Ltd (NSE:ABBOTTINDIA) is a subsidiary of the global healthcare company, Abbott Laboratories. It was established in 1944 and…

SMS Pharmaceuticals Ltd (SMSPHARMA) Q3 FY23 Earnings Concall Transcript

SMS Pharmaceuticals Ltd (NSE:SMSPHARMA) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vamsi Krishna Potluri -- Executive Director Unidentified Speaker --…

Earnings Summary Of Hikal Limited For Q3 FY23

Hikal Limited (NSE: HIKAL) is a leading Indian life sciences company with a global presence. The company specializes in developing…

IPCA Laboratories Ltd (IPCALAB) Q3 FY23 Earnings Concall Transcript

IPCA Laboratories Ltd (NSE:IPCALAB) Q3 FY23 Earnings Concall dated Feb. 16, 2023. Corporate Participants: Ajit Kumar Jain -- Joint Managing Director Harish…

Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT): Q3FY23 Results Out; Total Income rise 15% YoY

Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT) is a pharmaceutical company based in India. It is engaged in the development, manufacture,…

Shilpa Medicare Ltd (SHILPAMED) Q3 FY23 Earnings Concall Transcript

Shilpa Medicare Ltd (NSE: SHILPAMED) Q3 FY23 Earnings Concall dated Feb. 15, 2023 Corporate Participants: Vishnukanth Bhutada -- Managing Director Alpesh Dalal -- Chief…

Biocon Limited (BIOCON) Q3 FY23 Earnings Concall Transcript

Biocon Limited (NSE:BIOCON) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Saurabh Paliwal -- Head - Investor Relations Kiran Mazumdar…

Marksans Pharma Limited Q3 FY23 Earnings Conference Call Insights

Key highlights from Marksans Pharma Limited (MARKSANS) Q3 FY23 Earnings Concall Q&A Highlights: [00:08:54] Riddhesh Gandhi from Discovery Capital asked…

Earnings Summary Of Granules India Limited For Q3 FY23

Granules India Limited (NSE: GRANULES) is a pharmaceutical manufacturing company based in Hyderabad, India. The company was founded in 1984…

Marksans Pharma Limited (MARKSANS) Q3 FY23 Earnings Concall Transcript

Marksans Pharma Limited (NSE:MARKSANS) Q3 FY23 Earnings Concall dated Feb. 14, 2023. Corporate Participants: Mark Saldanha -- Managing Director and Chief Executive…